Global Growth Hormone Deficiency Market Is Expected To Foresee Significant Growth During The Forecast Period. North America to Witness the Highest Growth

The global growth hormone deficiency market is expected to grow significantly by 2028 expanding at a reasonable CAGR of around 7% during the forecast period (2022-2028F). Human growth hormone (HGH), produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function.

For a detailed analysis of the growth hormone deficiency browse through – https://univdatos.com/report/growth-hormone-deficiency-market/

The rising prevalence of growth hormone deficiency syndromes is a major factor that drives the market for HGH hormones. The rising awareness about the severity of the drug and increasing early diagnosis are responsible for the rising demand for the growth hormone. For instance, as per Medline, Turner syndrome is a chromosomal condition that affects development in females. The most common feature of Turner syndrome is short stature, which becomes evident by about age 5. This condition occurs in about 1 in 2,500 newborn girls worldwide.

For a detailed analysis of the market drivers of growth hormone deficiency browse through – https://univdatos.com/report/growth-hormone-deficiency-market/

Based on the Product, the market is categorized into powder and solvent. The powder segment grabbed major market share in the growth hormone drug market in 2020. This is mainly due to the stability of the powdered under extreme temperatures. Furthermore, the higher shelf life of the drug category is attributed to a significant market share of the segment in the growth hormone deficiency market.

Based on the application, the market is categorized into growth hormone deficiency, idiopathic short stature, turner syndrome, small for gestational age, Prader-Willi syndrome, and others. The growth hormone deficiency category is anticipated to witness significant growth during the forecast period. This is mainly due to the rising incidences of growth hormone deficiency. For instance, as per Medline, The incidence of isolated growth hormone deficiency is estimated to be 1 in 4,000 to 10,000 individuals worldwide.

Based on the distribution channel, the market is categorized into retail pharmacies, hospital pharmacies, and online pharmacies. The online pharmacies segment grabbed major market share in the growth hormone drug market in 2020. This is mainly due to the adoption of the rapidly IoTs in the healthcare sector and increasing internet penetration enables the significant segmental growth of the segment during the forecast period. Around 66% of the world’s population is using the internet which accounted for 5.25 billion which is expected to grow in the future.

Request for a Sample of the report browse through – https://univdatos.com/pre-book-report-php/?product_id=29602

Additionally, the report provides detailed report also provides insights into the global growth hormone deficiency market according to the regions such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a significant market for the growth hormone deficiency industry. The presence of sophisticated healthcare infrastructure and the intensive focus on research & development is responsible for the significant market share of the region in the growth hormone deficiency market. For instance, as per the National Science Board, the United States spent $607.5 billion in R&D activity, with $101.1 billion (17%) of annual R&D spending classified as basic research

Novo Nordisk A/S, Pfizer, Inc, Eli Lilly and Company, Novartis AG, Merck KGaA, Roche, Ferring Pharmaceuticals, Teva Pharmaceutical Industries, Ltd, Ipsen, and Cipla Inc. are some of the key players operating in the global growth hormone deficiency market. Several M&As along with partnerships have been undertaken by these players to develop various types of growth hormone deficiency.

Global Growth Hormone Deficiency Market Segmentation

Market Insight, by Product

• Powder
• Solvent

Market Insight, by Application

• Growth hormone deficiency
• Idiopathic short stature
• Turner syndrome
• Small for gestational age
• Prader-Willi syndrome
• Others

Market Insight, by Distribution Channel

• Retail pharmacies
• Hospital pharmacies
• Online pharmacies

Market Insight, by Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Australia
  • Japan
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• Novo Nordisk A/S
• Pfizer, Inc
• Eli Lilly and Company
• Novartis AG
• Merck KGaA
• Roche
• Ferring Pharmaceuticals
• Teva Pharmaceutical Industries, Ltd
• Ipsen
• Cipla Inc.